Clinical Outcomes in Non–Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling
暂无分享,去创建一个
A. Tsao | D. Gibbons | F. Fossella | H. Tran | Jianjun Zhang | R. Colen | Islam Hassan | B. Carter | Y. Elamin | G. Blumenschein | B. Glisson | M. Altan | V. Lam | W. Rinsurongkawong | L. Hong | M. Vasquez | Melvin Rivera | J. Heymach | Nabil A. Elshafeey | Lauren E. Byers | N. Elshafeey | Melvin J. Rivera